Metropolitan Life Insurance Company (MetLife)’s Mesa Laboratories MLAB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-288	Closed	-$31.6K	–	1281
2024 Q1	$31.6K	Hold	288	–	–	﹤0.01%	1639
2023 Q4	$30.2K	Hold	288	–	–	﹤0.01%	1719
2023 Q3	$30.3K	Hold	288	–	–	﹤0.01%	1674
2023 Q2	$37K	Hold	288	–	–	﹤0.01%	1607
2023 Q1	$50.3K	Sell	288 -38	-12%	-$6.81K	﹤0.01%	1389
2022 Q4	$54.2K	Hold	326	–	–	﹤0.01%	1425
2022 Q3	$45.9K	Hold	326	–	–	﹤0.01%	1520
2022 Q2	$66.5K	Hold	326	–	–	﹤0.01%	1319
2022 Q1	$83.1K	Sell	326 -938	-74%	-$255K	﹤0.01%	1321
2021 Q4	$415K	Hold	1,264	–	–	0.01%	1558
2021 Q3	$382K	Sell	1,264 -154	-11%	-$43.8K	0.01%	1628
2021 Q2	$385K	Buy	1,418 +93	+7%	+$23.6K	0.01%	1693
2021 Q1	$323K	Sell	1,325 -61	-4%	-$16.8K	﹤0.01%	1701
2020 Q4	$397K	Hold	1,386	–	–	0.01%	1508
2020 Q3	$353K	Buy	1,386 +205	+17%	+$48.7K	0.01%	1440
2020 Q2	$256K	Hold	1,181	–	–	﹤0.01%	1644
2020 Q1	$267K	Sell	1,181 -18	-2%	-$4.44K	0.01%	1416
2019 Q4	$299K	Hold	1,199	–	–	﹤0.01%	1639
2019 Q3	$285K	Buy	1,199 +48	+4%	+$11.1K	﹤0.01%	1635
2019 Q2	$281K	Hold	1,151	–	–	﹤0.01%	1664
2019 Q1	$265K	Hold	1,151	–	–	﹤0.01%	1707
2018 Q4	$240K	Hold	1,151	–	–	﹤0.01%	1687
2018 Q3	$214K	Hold	1,151	–	–	﹤0.01%	1966
2018 Q2	$243K	Hold	1,151	–	–	﹤0.01%	1815
2018 Q1	$171K	Hold	1,151	–	–	﹤0.01%	1991
2017 Q4	$143K	Sell	1,151 -1,056	-48%	-$148K	﹤0.01%	2106
2017 Q3	$330K	Hold	2,207	–	–	﹤0.01%	1973
2017 Q2	$316K	Sell	2,207 -49	-2%	-$6.96K	﹤0.01%	2028
2017 Q1	$277K	Hold	2,256	–	–	﹤0.01%	2062
2016 Q4	$277K	Hold	2,256	–	–	﹤0.01%	2143
2016 Q3	$258K	Hold	2,256	–	–	﹤0.01%	2167
2016 Q2	$277K	Hold	2,256	–	–	﹤0.01%	2106
2016 Q1	$217K	Hold	2,256	–	–	﹤0.01%	2123
2015 Q4	$224K	Hold	2,256	–	–	﹤0.01%	2178
2015 Q3	$251K	Buy	2,256 +198	+10%	+$20.9K	﹤0.01%	2118
2015 Q2	$183K	Sell	2,058 -259	-11%	-$21.9K	﹤0.01%	2457
2015 Q1	$167K	Hold	2,317	–	–	﹤0.01%	2134
2014 Q4	$179K	Buy	+2,317	New	+$170K	﹤0.01%	2487
2014 Q3	–	Sell	-2,238	Closed	-$188K	–	2704
2014 Q2	$188K	Hold	2,238	–	–	﹤0.01%	2557
2014 Q1	$202K	Hold	2,238	–	–	﹤0.01%	2453
2013 Q4	$176K	Hold	2,238	–	–	﹤0.01%	2556
2013 Q3	$151K	Buy	+2,238	New	+$143K	﹤0.01%	2618

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MLAB Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Mesa Laboratories (MLAB) in Q2 2024, closing a stake of 288 shares — an estimated $31.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MLAB in Q3 2013 and held it in 42 quarters. The position peaked at $415K in Q4 2021. 154 funds tracked by Wall St. Rank hold MLAB as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Mesa Laboratories position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 288 Mesa Laboratories shares in Q2 2024, an estimated $31.6K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Mesa Laboratories in Q3 2013 and held it in 42 quarters.
Metropolitan Life Insurance Company (MetLife)'s Mesa Laboratories position peaked at $415K in Q4 2021.
154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.